Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1484 participants.
Also called NCT07288749
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,484 participants
- Sponsor
- Anhui Provincial Hospital
- Beijing Anzhen Hospital
- Chinese Academy of Medical Sciences, Fuwai Hospital
- First Affiliated Hospital of Xinjiang Medical University
- First Hospital of China Medical University
- Nanjing Medical University
- Second Xiangya Hospital of Central South University
- Shanghai Zhongshan Hospital
- The First Affiliated Hospital of Air Force Medical University
- The First Affiliated Hospital of Zhengzhou University
- Tongji Hospital
- Wuhan Central Hospital
- Zhongnan Hospital
- Registry
-
NCT07288749
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07288749. Randomized; quadruple masking; primary purpose treatment. Start 2026-01-01 (anticipated); primary completion 2030-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.
- Acronym
- GLID-HF
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Condition
- Chronic Heart Failure (CHF)
- Intervention (Drug)
- Glimepiride (oral)
- Intervention (Drug)
- Placebo
- Lead sponsor
- Tongji Hospital
- Collaborator
- Shanghai Zhongshan Hospital
- Collaborator
- Nanjing Medical University
- Collaborator
- Second Xiangya Hospital of Central South University
- Collaborator
- Huaxi Hospital
- Collaborator
- Zhongnan Hospital
- Collaborator
- Xiangya Hospital
- Collaborator
- Beijing Anzhen Hospital
- Collaborator
- The First Affiliated Hospital of Air Force Medical University
- Collaborator
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator
- The First Affiliated Hospital of Zhengzhou University
- Collaborator
- First Affiliated Hospital of Xinjiang Medical University
- Collaborator
- Anhui Provincial Hospital
- Collaborator
- Southwest Medical University
- Collaborator
- First Hospital of China Medical University
- Collaborator
- Wuhan Central Hospital
- Collaborator
- Tianjin Medical University
Registry records
Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry organizations 13
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 53 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 32 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 13 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 31 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 25 trials in this atlas.
Record details
- Record id
cardio:ct-nct07288749- Content hash
d88b43f5124c7ba633ec9d03276becc04b52094bc9fbbe53df64dd516f39c344